The association of statin therapy with clinicopathologic outcomes and survival among patients with localized renal cell carcinoma undergoing nephrectomy.

[1]  M. Thurnher,et al.  Mevalonate metabolism in cancer. , 2015, Cancer letters.

[2]  L. Murray,et al.  Statin use after colorectal cancer diagnosis and survival: a population-based cohort study. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  T. Ahern,et al.  Statins and breast cancer prognosis: evidence and opportunities. , 2014, The Lancet. Oncology.

[4]  W. Jiao,et al.  Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway , 2013, PloS one.

[5]  S. Jeon,et al.  Effects of statins on the prognosis of local and locally advanced renal cell carcinoma following nephrectomy. , 2013, Molecular and clinical oncology.

[6]  Chun-Yuh Yang,et al.  Statin use and the risk of kidney cancer: a population-based case–control study , 2012, Expert opinion on drug safety.

[7]  N. Clarke,et al.  The differential effects of statins on the metastatic behaviour of prostate cancer , 2012, British Journal of Cancer.

[8]  Oliver Nussbaumer,et al.  Novel Aspects of Mevalonate Pathway Inhibitors as Antitumor Agents , 2012, Clinical Cancer Research.

[9]  P. Russo,et al.  The association between statin medication and progression after surgery for localized renal cell carcinoma. , 2012, The Journal of urology.

[10]  T. Choueiri,et al.  Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts , 2012, Cancer.

[11]  A. Levine,et al.  Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway , 2012, Cell.

[12]  E. Jonasch,et al.  Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma. , 2011, Clinical genitourinary cancer.

[13]  A. Keating,et al.  Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer. , 2010, European urology.

[14]  S. Freedland,et al.  Association between Statins and Prostate Tumor Inflammatory Infiltrate in Men Undergoing Radical Prostatectomy , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[15]  D. Nowis,et al.  Statins potentiate cytostatic/cytotoxic activity of sorafenib but not sunitinib against tumor cell lines in vitro. , 2010, Cancer letters.

[16]  C. Fong,et al.  Statins, stem cells, and cancer , 2009, Journal of cellular biochemistry.

[17]  E. Pukkala,et al.  Statins and cancer: A systematic review and meta-analysis. , 2008, European journal of cancer.

[18]  In Sung Song,et al.  Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis‐associated colon cancer in mice , 2008, International journal of cancer.

[19]  L. Platanias,et al.  Statin-Dependent Suppression of the Akt/Mammalian Target of Rapamycin Signaling Cascade and Programmed Cell Death 4 Up-Regulation in Renal Cell Carcinoma , 2008, Clinical Cancer Research.

[20]  B. Strom,et al.  Statin Use and the Risk of 10 Cancers , 2007, Epidemiology.

[21]  Stephen B. Gruber,et al.  Statins and cancer prevention , 2005, Nature Reviews Cancer.

[22]  M. Lohuizen,et al.  Stem Cells and Cancer The Polycomb Connection , 2004, Cell.

[23]  J. Cheville,et al.  An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. , 2002, The Journal of urology.

[24]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[25]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[26]  G. Batist,et al.  Use of statins and the risk of death in patients with prostate cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  F. Arvelo,et al.  [Stem cells and cancer]. , 2014, Investigacion clinica.

[28]  E. Kopel,et al.  Statin use and reduced cancer-related mortality. , 2013, The New England journal of medicine.

[29]  M. Ankem,et al.  Statins might reduce risk of renal cell carcinoma in humans: case-control study of 500,000 veterans. , 2008, Urology.

[30]  Kelvin K. W. Chan,et al.  The statins as anticancer agents. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .